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PURPOSE. To ascertain cellular constituents within islands of preserved retina in choroideremia
(CHM) by multimodal imaging.
METHODS. CHM probands (16) and female carriers (9) of CHM were studied. Near-infrared
autofluorescence (NIR-AF; 787-nm excitation; emission, >830 nm), short-wavelength
autofluorescence (SW-AF; 488-nm excitation, 500- to 680-nm emission), and spectral-domain
optical coherence tomography (SD-OCT) images were acquired with a confocal scanning laser
ophthalmoscope. SW-AF intensities were measured by quantitative fundus autofluorescence
(qAF), and NIR-AF intensity profiles were analyzed. Retinal thicknesses and visual acuity were
measured.
RESULTS. In 19 of 31 eyes of affected males, islands of preserved NIR-AF signal were also visible
as fluorescence signal in SW-AF images. Notable in 12 eyes were areas of speckled SW-AF that
was hypoautofluorescent in the NIR-AF image. Islands of preserved NIR-AF and SW-AF signal
were often associated with the presence of visible but thinned outer nuclear layer and
discontinuous interdigitation zone, ellipsoid zone, and external limiting membrane. NIR-AF
profiles revealed that even in areas of preserved retina, the NIR-AF signal from retinal pigment
epithelium (RPE) melanin is greatly reduced. qAF was reduced overall. The fundus of carriers
was characterized by a mosaicism in which patches of reduced NIR-AF colocalized with
reduced SW-AF.
CONCLUSIONS. In CHM-affected males, the presence of RPE was indicated by an NIR-AF signal
and the absence of hypertransmission of OCT signal into the choroid. RPE preservation was
associated with better visual acuity. In carriers, patches of reduced SW-AF colocalized with
decreased NIR-AF and qAF was severely reduced.
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Choroideremia (CHM) is an X-linked recessive disorder thataffects ~1 in 50,000 individuals1 and is characterized by
the progressive degeneration of photoreceptor cells, retinal
pigment epithelium (RPE), and the underlying choroid in
affected males. CHM typically has onset in juveniles and is
attributable to pathogenic variants in the CHM gene (OMIM
300390)2,3 that encodes the ubiquitously expressed Rab escort
protein 1 (REP-1)4 expressed by rods and RPE.5 REP1
participates in the lipid modification (prenylation) of Rab
GTPases. The latter are vital regulators of intracellular vesicular
transport and organelle movement. The deficiency in REP1 can
be compensated for by REP2 in most cell types but, as
evidenced by CHM, adequate compensation does not occur in
retina6,7; the result is widespread chorioretinal atrophy.8,9 One
of the Rabs affected in CHM is Rab27a, which is required for
melanosome movement into the apical processes of RPE
cells.10
Disease-associated variants in CHM consist predominantly of
null or loss-of-function alleles2; however, phenotypes can vary
across individuals. Disease onset in affected males is generally
marked by slowed dark adaptation, followed by progressive
constriction of the visual field and degeneration of RPE,
choroid, and photoreceptor cells. Spectral-domain optical
coherence tomography (SD-OCT) imaging of affected males
has revealed zones of macular sparing bordered by the loss of
interdigitation zone (IZ) and ellipsoid zone (EZ), with outer
nuclear layer (ONL) thinning, and increased signal transmission
posterior to RPE/Bruch’s membrane.11–13 Foveal structure and
function can be retained for several decades.12–15
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Heterozygous female carriers of CHM mutations are
typically asymptomatic. However, some carriers report nycta-
lopia in middle and late life, and full-field electroretinography
(ERG) recordings can be abnormal.16–18 In short-wavelength
autofluorescence (SW-AF) images, patches of hyperautofluor-
escence alternate with hypoautofluorescence,17–19 a mosai-
cism that is considered to reflect random X-inactivation. By
multifocal ERG, abnormal responses corresponding to the
mosaic pattern can be recorded.19,20 In SD-OCT scans, female
carriers occasionally present with hyperreflective foci that
interrupt photoreceptor-attributable bands and correspond to
hyperautofluorescent foci in the macula.11,17
Despite histopathologic studies,21 in vivo imaging, and the
availability of mouse models,22,23 it remains uncertain as to
whether degeneration is initiated in photoreceptor cells5,13,24
or RPE25–29 or whether it is a simultaneous process in both cell
types.30 A more consistent observation is that the loss of
choroidal tissue occurs secondary to the degeneration of RPE
and photoreceptors rather than being the site of the primary
changes.5
Gene replacement therapy for the treatment of CHM is
currently being explored31–33 (ClinicalTrials.gov numbers,
NCT02553135, NCT02407678, and NCT02341807), and re-
cent results from a phase 1/2 clinical trial indicate that
persistent, clinically significant visual acuity gains can be
achieved in eyes in which rapid visual acuity loss would
otherwise be expected.34 The aim of this study was to
correlate SW-AF and near-infrared fundus autofluorescence
(NIR-AF) signal with SD-OCT images in affected males and
female carriers of CHM to better identify the cellular
constituents in preserved central islands of the retina. In the
healthy eye, SW-AF and NIR-AF are primarily generated in RPE
cells, with SW-AF emission originating from retinal bisretinoid
lipofuscin and NIR-AF from RPE melanin.35,36 We have also
implemented quantitative approaches to analyze SW-AF by
quantitative fundus autofluorescence (qAF) and to measure
NIR-AF intensities.
METHODS
Patients, Clinical Evaluation, and Genetic Testing
A retrospective observational study of images acquired from
patients presenting to the Department of Ophthalmology
Columbia University was performed. Institutional review
board/ethics committee approval was obtained under protocol
AAAR8743. All study-related procedures adhered to the tenants
established in the Declaration of Helsinki.
All patients underwent a comprehensive ophthalmic
examination by a retina specialist (SHT). The fundus was
examined under pupillary dilatation and best corrected visual
acuity (BCVA) was determined. The diagnosis of CHM in
probands was based on clinical findings and confirmed by
direct sequencing of the CHM gene. Heterozygous female
carriers were identified through affected probands (relatives)
and subsequently screened for the causative heterozygous
mutation.
Image Acquisition and Analysis
NIR-AF images (308 and 508 field, 787-nm excitation, >830-nm
emission without injection of dye) were captured with
Heidelberg retinal tomography 2-scanning laser ophthalmo-
scope (Heidelberg Engineering, Heidelberg, Germany). For
NIR-AF quantification, nonnormalized 308 3 308 images
acquired at a fixed sensitivity of 96 (available for 9 probands
and 3 CHM carriers) were analyzed using open source software
(Fiji; National Institutes of Health, Bethesda, MD, USA). Pixel
gray levels were determined at 0.25-mm intervals along a
horizontal line through the fovea, and profiles were aligned.
The gray level values were then adjusted by subtracting the
NIR-AF image gray level offset value provided by the
Heidelberg software. The mean and 95% confidence intervals
(CIs) were plotted as a distance along the x axis in the
temporal (0 to 4 mm) and nasal (0 to þ4 mm) direction
relative to the fovea, and a comparison was made to 19 healthy
subjects as previously described.37 The healthy cohort
consisted of subjects without eye disease, the mean age was
35.3 6 9.4 SD years (range, 12.7–52.7 years), and 10 subjects
identified themselves as Caucasian, with 3 as Hispanic, 4 Asian,
and 2 African American. SW-AF (blue autofluorescence; 488-
nm excitation, 500- to 680-nm emission) images (308 3 308
fields) were acquired with a modified confocal scanning laser
ophthalmoscope (Spectralis HRAþOCT; Heidelberg Engineer-
ing) in automatic real-time tracking capture mode. qAF was
measured at an eccentricity of 78 to 98 with normalization as
previously described.38 An analysis of a fixed foveal segment
(18) in both patients and controls was also performed. A
comparison was made to a normative database of healthy eyes
(374 eyes; age range, 5–65 years).38
SD-OCT line and volume scans in high-resolution mode and
a corresponding infrared reflectance fundus image were
acquired with a confocal scanning laser ophthalmoscope
(Spectralis HRAþOCT; Heidelberg Engineering). Foveal thick-
ness (FT) and subfoveal choroidal thickness (SFT) were
manually measured using the caliper tool in the Heidelberg
Explorer (HEYEX) software. FT was defined as the distance
from the internal limiting membrane to the outer border of
RPE-Bruch’s membrane and SFT as the distance between the
outer border of the RPE-Bruch’s membrane complex and the
chorioscleral border under the fovea.
Color fundus photographs were obtained with a FF 450plus
Fundus Camera (Carl Zeiss Meditec, Jena, Germany). Ultra-
widefield (2008) high-resolution Optomap images were cap-
tured with Optos (Optos Daytona; Optos, Inc., Marlborough,
MA, USA) in the composite pseudocolor and green autofluo-
rescence (excitation 532 nm) mode.
Statistical Analysis
Statistical analyses were performed using the Prism 5 software
(GraphPad Software, La Jolla, CA, USA) and the statistical tests
as indicated. Statistical significance was evaluated by compar-
ing CIs and by Wilcoxon-Mann-Whitney Test as appropriate.
The Bland-Altman analysis was used to assess interobserver
agreement.
RESULTS
Fundus Imaging in Affected Patients
The study cohort consisted of 16 affected patients (31 eyes);
one eye of one patient was excluded because the advanced
stage of CHM precluded the acquisition of NIR-AF and qAF
images. All affected patients were male with a mean age of 44.9
years (range, 10.2–77.2) at the time of examination. BCVA
ranged from 20/20 to 20/150 (Table). Demographic, clinical,
and genetic data along with familial relationships are summa-
rized in the Table. All images were evaluated independently by
two investigators (MP, JRS). Disease-causing mutations in the
CHM gene were detected in all affected patients and carriers
who underwent genetic screening. P9 and C4 were not
screened but were clinically diagnosed and reported a positive
family history of CHM, respectively. In total, 19 unique variants
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were detected in the cohort (Supplementary Table S1), the
majority of which were frameshifts (26.3%), large deletions
(21.1%), and non-coding or intronic (26.3%). All intronic
mutations occurred within canonical splice sites (61 and 62)
and are strongly predicted to result in skipping of the
subsequent or adjacent exon. All missense variants are
predicted to be pathogenic or previously associated with
CHM (single nucleotide polymorphism).
Patients exhibited varying degrees of chorioretinal atrophy.
In color fundus photographs, regions of advanced degenera-
tion and widespread depigmentation were pale due to the
reflection of light from bare sclera (Fig. 1A: proband/patient 7
[P7], white asterisk). In areas of exposed choroid, pigment and
choroidal vessels were visible (Fig. 1 A: P7, P5). The choroidal
vessel patterns visible in the color fundus photographs
typically matched similar patterns in NIR-AF images (Figs. 1A
and B: P7, P5). In areas of outer retinal atrophy, choroidal
vessels were outlined by the diffuse NIR-AF emanating from
residual choroidal pigment (Fig. 1B: P7, P5, P15, P6).
In 8 patients (13 eyes), distinct islands of preserved RPE in
NIR-AF images presented as NIR-AF situated anterior to
choroidal vessels (Fig. 1B: P7, P5, and P15 as green, yellow,
and red asterisks, respectively). In another 3 patients (6 eyes),
NIR-AF presented as foci of a more limited size. In 23 eyes for
which color fundus photographs were available, 9 eyes served
as examples in which islands of NIR-AF colocalized with
pigmented zones in color fundus photographs. These islands
were either dense (Fig. 1B: P5, green asterisk) or less
compacted (Fig. 1B: P7, green asterisk). In 19 of 31 eyes,
preserved NIR-AF signal was also visible as fluorescence signal
in SW-AF images (Figs. 1B and 1C: P7, P5, and P15; green and
yellow asterisks in figure panels). However, in the remaining
12 eyes (6 patients), nummular pigment visible in color fundus
photographs and NIR-AF images was remarkably dark in SW-AF
images (Fig. 1B, 1C: P7, P6, red asterisks) and, as discussed
below, was typically associated with thinning of outer retina.
Also notable in 12 eyes and illustrated for P6 was a large
area of speckled SW-AF that was hypoautofluorescent in the
NIR-AF image (Figs. 1B, 1C: P6, blue asterisk). Similarly, in P5,
the central island of residual AF included finger-like extensions
that exhibited signal in the SW-AF image but not in the NIR-AF
image (Fig. 1C: P5, blue arrowhead). The presence of pigment
in color photographs that corresponds to a weak signal in NIR-
AF images (Fig. 1A–C: P5, white arrow) may be indicative of
choroidal melanin.
In SD-OCT scans, areas of severe chorioretinal atrophy were
defined by an absence of photoreceptor-attributable reflectiv-
ity bands (Fig. 1D: P7, white asterisk and bracket). Areas of RPE
loss and absent outer retinal bands were also associated with
hyporeflectance and could be identified by increased signal
transmission into the choroid; the latter was visible as vertical
streaks extending posterior to RPE/Bruch’s membrane (Fig.
1D: P7, purple arrowheads). In some of these areas, the
choroid had also atrophied. With severe outer retinal
degeneration, the reflectivity layer attributable to inner nuclear
layer descended into the gap (Fig. 1D: P6, red arrow).
On the other hand, islands presenting with preserved NIR-
AF and SW-AF signals were often associated with the presence
of a visible but thinned ONL, nondetectable IZ and EZ, and
external limiting membrane (ELM) that were discernible to
TABLE. Demographic, Clinical, and Genetic Characteristics of Affected Patients and Heterozygous Carriers of the Choroideremia Study Cohort
Patient
Number
Age
(y) Sex Race/Ethnicity
LogMAR BCVA
Study
Eye
CHM Variant* cDNA
(Protein) Zygosity RelationshipOD OS
P1 43 M Caucasian 0.00 0.79 OU c.877C>T (p.Arg293†) Hemizygous Proband
P2 52 M African-American 0.30 0.30 OU c.49þ1G>A (p.?) Hemizygous Proband
P3 46 M Caucasian 0.87 0.79 OU c.1349G>T (p.Arg450Met) Hemizygous Proband
P4 36 M Caucasian 0.30 0.00 OU c.315-2A>G (p.?) Hemizygous Proband
P5 68 M Caucasian 0.39 0.30 OU c.1771-1G>A (p.?) Hemizygous Proband
P6 28 M African-American 0.30 0.17 OU Deletion of Exon 12‡ Hemizygous Proband
P7 57 M Caucasian 0.00 0.20 OU c.82del (Ser28Glnfs†32) Hemizygous Proband
P8 58 M Caucasian 0.47 0.40 OU c.1520A>G (p.His507Arg) Hemizygous Proband
P9 60 M African-American 0.10 0.10 OU Not screened Hemizygous Proband
P10 31 M Iranian 0.80 0.00 OU c.1237_1328del (p.Ser413Valfs†18) Hemizygous Proband
P11 77 M Caucasian 0.40 0.60 OU Deletion of Exons 6 and 7‡ Hemizygous Proband
P12 51 M Caucasian 0.40 0.40 OU c.1580_1584del (p.Leu527Cysfs†5) Hemizygous Proband
P13 52 M Caucasian 0.10 0.10 OS Deletion of Exons 9 and 10‡ Hemizygous Proband
P14 21 M Caucasian 0.00 0.10 OU c.1584_1587del (p.Val529Hisfs†7) Hemizygous Proband
P15 31 M Caucasian/North-African 0/0 0.00 OU c.819þ1G>A (p.?) Hemizygous Proband
P16 10 M Indian 0.10 0.10 OU Deletion of entire CHM locus‡ Hemizygous Proband
Carrier
C1 53 F Caucasian 0.30 0.30 OU c.1584_1587del (p.Val529Hisfs†7) Heterozygous Sister (P14)
C2 51 F African-American 0.10 1.00 OU c.1349G>T (Arg450Met) Heterozygous Sister (P3)
C3 76 F Caucasian 0.10 0.10 OU c.49þ1G>A (p.?) Heterozygous Mother (P2)
C4 49 F African-American 0.00 0.00 OU Not screened Heterozygous
C5 49 F African-American 0.00 0.00 OU Deletion of Exon 12‡ Heterozygous Mother (P6)
C6 61 F Caucasian 0.50 0.47 OU c.757C>T (p.Arg253†) Heterozygous
C7 65 F Caucasian 0.10 0.30 OU c.1584_1587del (p.Val529Hisfs†7) Heterozygous
C8 54 F Caucasian 0.00 0.17 OU c.189G>C (p.Gln63His) Heterozygous
C9 29 F Hispanic 0.00 0.00 OU c.940G>A (p.Gly314Arg) Heterozygous
P, patients; C, carrier; M, male; F, female; OD, right eye; OS, left eye; OU, both eyes.
* GRCh38 assembly/NM_000390.3.
† Nonsense mutation.
‡ Failure of amplification by polymerase chain reaction.
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variable extents or absent (Fig. 1D: P7, P5, P15, green bracket).
In the SD-OCT scan presented for P7, outer retinal tubulations
(ORTs) were visible in an island that exhibited NIR-AF signal
but was devoid of SW-AF (Fig. 1D: P7, red asterisk). Here,
hyperreflectivity associated with the dense pigment reduced
transmission of the OCT signal into the choroid (Fig. 1D: P7,
red asterisk). Foci of the SW-AF signal in the absence of NIR-AF
appeared to be associated with thinned ONL and discontinu-
ous or loss of IZ, EZ, and ELM bands along, with hyper-
transmission into the choroid (Fig. 1C: P5, AF blue arrowhead;
D: P5, blue asterisk).
Preservation of the fovea and parafovea as exhibited by P15
was identified by the increased central NIR-AF signal and
decreased foveal SW-AF, both of which are characteristic of the
macula in healthy eyes (Fig. 1B, 1C: P15). In addition, the SD-
OCT image revealed a relatively intact outer retina (Fig. 1D:
P15, green bracket). Of additional interest is the speckled
autofluorescence that characterized the extrafoveal region in
the SW-AF image. This brightly speckled macular area in the
SW-AF image was hypoautofluorescent in the NIR-AF image
(Figs. 1B, 1C: P15).
Fundus Imaging in CHM Carriers
Nine heterozygous carriers were also included in the study (18
eyes). The mean age in the carrier group was 54 (29.3–75.5)
and visual acuity ranged from 20/20 to 20/200 (Table).
In SW-AF and NIR-AF images, 9 carriers (18 eyes) exhibited
AF mottling with mosaic-like patterns of alternating hypo- and
iso-AF extending throughout the posterior pole (18/18 eyes)
(Figs. 2B, 2C). The areas of reduced NIR-AF in the mosaicism
colocalized with foci of reduced SW-AF, although the contrast
between hypo- and hyper-AF signal in the NIR-AF images was
more pronounced than the contrast in corresponding areas in
the SW-AF images (Figs. 2B1, 2C1).
Carrier 3 presented with more advanced peripapillary and
macular atrophy in the color fundus image (Fig. 2D, carrier 3),
with nummular areas of reduced NIR-AF and SW-AF signal (Fig.
2B, carrier 3). In SD-OCT scans acquired from carrier 3,
thinning of the outer retina was readily observable as was an
ORT and hypertransmission into the choroid (Fig. 2A, carrier
3). In all 9 carriers, hyperreflective disturbances of the EZ and
IZ were observed in the SD-OCT scans, and hypertransmission
into the choroid could be observed in association with these
irregularities (Fig. 2A, carrier 1). These aberrations were also
visible as bright hyperautofluorescent flecks in both SW-AF and
NIR-AF images (Fig. 2B, carriers 1 and 2).
qAF in CHM-Affected Probands
To assess SW-AF intensities, qAF levels were measured in those
patients for whom qAF imaging was available (6 affected
patients, 7 eyes; P1, P5, P7, P9, P10, and P15; age, 31–67 years)
and who exhibited foveal sparing. To better visualize the
distribution of SW-AF intensities in relation to the central
retinal islands, we constructed qAF maps (scaled from 0-1200
qAF units) and compared CHM patients to age-matched healthy
eyes. The distribution of qAF signal in the CHM-affected
patients (Fig. 3A: P15, P6, P10) was nonuniform and distinctly
different than in the healthy age-similar eyes (Fig. 3C).
FIGURE 1. Multimodal fundus imaging of CHM probands (patients P7, P5, P15, and P6). Color fundus photographs (A) NIR-AF (B), SW-AF (C), and
SD-OCT (D) reveal islands exhibiting NIR-AF and SW-AF signals (green and yellow asterisk); residual pigment and NIR-AF signal devoid of SW-AF
(red asterisk); bare sclera (white asterisks); SW-AF signal in the absence of NIR-AF (blue asterisk, blue arrow); and hypertransmission of OCT signal
(pink arrowhead). In P5, retained pigment in A exhibits weak NIR-AF but no SW-AF (white arrow). In P6, severe outer retinal degeneration exists
with inner nuclear layer descent (red arrow). In SD-OCT scans (D) brackets indicate the corresponding area in the NIR-AF and SW-AF image. The
horizontal axis and extent of the corresponding SD-OCT image are indicated by the green lines in A–C.
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Specifically, throughout the macula, qAF was profoundly
reduced in the probands not just in the areas of choreoretinal
atrophy but also in the central areas of spared retina.
Measurements were acquired within a foveal segment (18). In
both fundus zones, the qAF values of the probands were either
within or below the range of the lower 95% CI in healthy eyes
(Fig. 3D).
qAF in CHM Carriers
Short wavelength fundus autofluorescence was measured by
qAF in 6 carriers (carriers 1, 4, 5, 7, 8, and 9; 12 eyes; age, 29–
65 years) for whom qAF images were available. Color-coded
qAF images revealed both an overall decrease in qAF and local
increases and decreases associated with the mosaicism of the
fundus (Figs. 4A, 4B: carriers 4, 1, and 5). SW-AF levels within
the macula (qAF8) in the eyes of heterozygous carriers fell
below or within the lower limits (95% CI) of qAF levels in
healthy eyes (Fig. 4D).
Quantitation of NIR-AF in Patients and Carriers
A semiquantitative analysis of NIR-AF intensities was performed
using images acquired from 9 probands (P6, P7, P9, P10, P11,
P12, P14, P15, and P16; 18 eyes; age, 10.2–77.2 years) and 3
carriers (C7, C8, and C9; 6 eyes; age range, 29.3–64.7 years).
Intensities extracted from horizontal NIR-AF profiles through
the fovea (Figs. 5A, 5B), revealed that for CHM probands, the
mean NIR-AF intensity was below the 95% CI for healthy eyes
(Fig. 5C, green trace versus red and yellow). Each NIR-AF
profile spanned atrophic regions and islands of preserved
tissue, thereby representing the signal from both exposed
choroid and relatively preserved RPE. Notably, even in the
central portions of the profiles corresponding to residual
retina, the NIR-AF signal was below the normal range (Fig. 5C).
Profiles of probands with central islands not visibly detectable
in NIR-AF images (Figs. 5B, yellow trace; 5C, NIR-AF) fell
below the 95% CI of probands with a preserved island emitting
detectable NIR-AF signal (Figs. 5A, red profile; 5C, NIR-AFþ).
Profiles of the carriers (Fig. 5C: blue trace) showed variability,
with the central foveal values being below the healthy 95% CI
(Fig. 5C, below, green trace).
Retinal Thickness and Visual Acuity in Relation to
NIR-AF Signal
FT and SFT were measured in all 16 probands (31 eyes). In the
group with detectable NIR-AF signal emitted from the retinal
island, the average (6SD) FT and SFT were higher (FT, 191.6
lm 6 52.06; SFT, 148.42 6 81.8) than in those with no NIR-AF
signal originating from the central island (FT, 155.08 6 102.5;
FIGURE 2. Multimodal imaging of choroideremia carriers (C1, C2, and C3). SD-OCT (A), NIR-AF (B), and SW-AF (C). Areas in the rectangles in B and
C are expanded in B1 and C1, respectively. The horizontal axis and extent of the corresponding SD-OCT image are indicated by the green lines in B
and C. Fundus color photos are presented in the lower panel (D).
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SFT, 124.6 6 74.3); however, that difference was not
statistically significant (P ¼ 0.21 and P ¼ 0.58, Wilcoxon-
Mann-Whitney Test). The Bland-Altman analysis (Supplemen-
tary Fig. S1A) of the FT measurements obtained from the two
observers revealed the mean of the differences to be 6.23
(615.21, SD of the difference between the observers). The
95% limits of agreement between observers (estimated as
61.963 SD) were23.6 to 36.0, indicating that measurements
by observer 1 could be 23.6 units below or 36 units above
observer 2. In the case of choroidal thickness (Supplementary
FIGURE 3. qAF color-coded images of P15, P6, and P10 (A). Corresponding SW-AF images (B). Healthy age-similar qAF color-coded image (C). qAF
values acquired from foveal area (18 eccentricity; circle in C) and plotted as a function of age for healthy subjects (blue circles), CHM probands (P1,
P5, P7, P9, P10, and P15; red circles), and CHM carriers (carriers 1, 3, 4, 7, 8, and 9; yellow circles) (D).
FIGURE 4. qAF in CHM carriers. qAF color-coded images of CHM carrier 4, carrier 1, and carrier 5 (A). Corresponding SW-AF images (B). Healthy
(age 55 years) qAF color-coded image (C). qAF8 values (yellow circles) acquired from 8 concentric segments (78–98 eccentricity; outlined in C) and
plotted as a function of age for carriers 1, 4, 5, 7, 8, and 9 (D). Mean (solid black line) 6 95% CIs (dashed lines).
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FIGURE 5. NIR-AF signal intensity profiles for CHM probands and carriers. NIR-AF images with profile overlay and SW-AF images for P15 (A) and P6
(B). Intensity profiles are presented as mean (solid line) and 95% CIs (dashed line). Horizontal intensity profiles through the fovea are shown for 6
patients exhibiting a central NIR-AF signal (NIR-AFþ; red profile) and for 3 patients having reduced or absent central NIR-AF signal (NIR-AF; yellow
profile). Comparison is made to intensity profile constructed from 19 healthy eyes (green profile) (C, above). Horizontal profiles through the fovea
are shown for 3 carriers (blue profile) and compared to healthy eyes (green profile) (C, below).
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Fig. S1B), the mean of the differences was 2.64 (614.5) and the
95% limits of agreement between observers was25.8 to 31.1.
The logMAR-equivalent BCVA ranged from 0 to 0.87. The
group with the preserved NIR-AF signal associated with a
preserved retinal island (10 patients) had a better mean visual
acuity (mean logMAR equivalent [6SD], 0.16 6 0.1) compared
to the group with absent NIR-AF signal (logMAR equivalent
[6SD], 0.46 6 0.2) (6 patients), and the difference proved to be
statistically significant (P¼0.003, Wilcoxon-Mann-Whitney Test).
DISCUSSION
In gene therapy trials for CHM, favorable outcomes after gene
replacement are considered more likely if the patients selected
for the clinical trial present with central retinal islands having
preserved RPE.34 Thus, in a previously unexplored approach, we
quantified the melanin signal originating primarily from RPE and
captured by the NIR-AF imaging platform to detect RPE within
preserved retinal islands in CHM. The importance of distinguish-
ing RPE intactness is reinforced by our finding that mean visual
acuity was higher in patients exhibiting NIR-AF signal.
Preserved retinal islands of variable size in P15, P5, and P7
(Fig. 1) were distinguished by the presence of SW-AF and NIR-
AF signals, intact or discontinuous IZ and EZ reflectivity bands
attributable to photoreceptor cells, and the absence of
hypertransmission into the choroid. Taken together, these
features indicated that RPE and photoreceptor cells were at
least partially intact.
In association with preserved retinal islands at other
locations, we observed that SW-AF signal could coexist with
absent or appreciably reduced NIR-AF signal. For instance, in P6,
the loss of RPE in residual fovea was indicated by the deficiency
in NIR-AF signal and hypertransmission of OCT signal into the
choroid due to reduced reflectance by RPE melanin (Figs. 1B,
1D). Nonetheless, an area of speckled SW-AF signal was also
visible (Fig. 1C). A comparable but smaller area of SW-AF
emission was detected in the fundus of P5, even as the NIR-AF
signal was diminished (Figs. 1B, 1C). In the SD-OCT scan
associated with this area, EZ and ELM were discontinuous, and
hypertransmission into the choroid was observed (Fig. 1D).
These signs of RPE atrophy (reduced or absent NIR-AF with
hypertransmission into the choroid) concomitant with the
presence of a SW-AF signal are inconsistent with the
assumption that SW-AF originates only from RPE cells. An
alternative source of this aberrant SW-AF signal39 is degener-
ating photoreceptor cells that are represented in P6 by the
discontinuous IZ, EZ, and ELM reflectivity layers in SD-OCT
images (Fig. 1D). Even in healthy eyes, the fluorophores of SW-
AF form in photoreceptor cells before phagocytic transfer to
RPE.36 Accordingly, in the absence of NIR-AF, the SW-AF
emission may originate from the photoreceptor outer and
inner segments that are degenerating secondary to RPE
atrophy. In support of this explanation, we have noted that
elevated SW-AF in the absence of NIR-AF signal is also observed
at positions of SD-OCT-detectable photoreceptor cell degener-
ation in other retinal disorders.39,40
In NIR-AF images of CHM-affected patients, we also
observed melanin signal in zones where there was decidedly
no SW-AF signal. Without the availability of an NIR-AF image, a
residual island in P7 (Fig. 1B) might have been overlooked. In
this example presented for P7 (Figs. 1A–D), hyperpigmentation
in color fundus photographs colocalized with a veil of AF in the
NIR-AF images, an absence of SW-AF, thinned ONL, a loss of EZ
and ELM reflectivity layers, and the presence of an ORT, yet no
hypertransmission into the choroid in the SD-OCT scan. A zone
having NIR-AF emission in P6 is also devoid of SW-AF (Figs. 1B–
D). One might suggest that the AF findings indicated the
presence of RPE that had retained melanin (the NIR-AF signal)
but were devoid of lipofuscin (absence of SW-AF signal).
However, because SW-AF is attenuated by RPE melanin, it is
also possible that the reduced SW-AF signal is a product of
increased melanin absorbance of the SW-AF exciting light.
Interestingly, we found that qAF intensities mapped to the
fundus by scaled color-coding were profoundly reduced not
only in CHM-affected patients but also in female CHM carriers.
As demonstrated in CHM carrier 1 (Fig. 4A), this qAF reduction
was not attributable to outer retinal degeneration in SD-OCT
scans (Fig. 2A). Moreover, the signal intensity was nonuniform
in both NIR-AF and SW-AF images. Specifically, in CHM carriers,
patches of reduced AF in SW-AF images colocalized with
reduced AF in NIR-AF images. It has been suggested that
nonuniform melanin distribution associated with CHM/REP-1
dysfunction represents an X-linked manifestation of altered
RPE melanosome movement.10 However, we have also studied
melanin pigment mosaicism in NIR-AF images of X-linked
albinism carriers (GPR143/OA1), and unlike in CHM carriers,
patches of reduced signal in NIR-AF images of GPR143/OA1
carriers colocalize with increased signal (not reduced signal) in
the SW-AF modality.37 Moreover, because the fundus changes
in CHM carriers develop with age18 and exhibit progression,41
random X-inactivation of REP-1 leading to melanosome
dysfunctioning10 is not sufficient to explain the mosaicism.
This is an interesting issue that we are currently exploring.
Whether RPE cells or photoreceptor cells are the first to
express the disease has been an issue of uncertainty. We
observed that choroidal vasculature was preserved even in
areas exhibiting outer retinal atrophy, as indicated by the loss
of EZ and ELM and increased OCT signal transmission into the
choroid (Fig. 1, P5), which is indicative of RPE loss.
Other observations indicate that a disease process takes place
in the RPE layer before the photoreceptors are affected in CHM.
For instance we observed ORTs in the outer retina of both CHM-
affected patients and carriers. The formation of ORTs is
considered to reflect a survival response by photoreceptors, is
particularly common under conditions such as geographic
atrophy that originates in RPE, and is considered to be a reaction
to loss or separation of photoreceptor cells from RPE.42 Other
structural changes in the outer retina that characterize late-onset
retinal degeneration43 have also been reported in carriers of
CHM.11 This is significant because late-onset retinal degeneration
is caused by mutations in the gene C1QTNF5, which encodes a
protein expressed by RPE.44 This too suggests that RPE may be
the primary site of the disease. We also note that despite the
presence of NIR-AF emission from some central retinal islands,
overall, the analysis of NIR-AF profiles through the fovea
indicated that the signal was lower than in healthy eyes.
A limitation of this study is the relatively small cohort, with
age trending toward older subjects. The inclusion of children
or young adults would have allowed us to evaluate retina at
earlier stages of disease. Additionally, we did not have
specimens that would have allowed us to correlate SW-AF,
NIR-AF, and SD-OCT findings with histopathologic changes.
The detection of preserved retinal islands in SW-AF images
of CHM-affected patients has been used to evaluate disease
progression in CHM.29 The presence of RPE in these islands
favors better visual acuity. Yet, we observed here that without
the availability of NIR-AF images, SW-AF images can be
misleading. We concur with a recent report that NIR-AF is
valuable for patient selection and as an outcome measure in
clinical trials.45
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